GVD
Showing 1 - 18 of 18
Classical Hodgkin Lymphoma, Refractory or Relapsed Classical Hodgkin Lymphoma Trial in Guangzhou (PD-1 inhibitor, PD-1
Recruiting
- Classical Hodgkin Lymphoma
- Refractory or Relapsed Classical Hodgkin Lymphoma
- PD-1 inhibitor
- PD-1 inhibitor, gemcitabine, vinorelbine and doxorubicin liposome
-
Guangzhou, Guangdong, China
- +2 more
May 6, 2022
Lymphoma, Large B-Cell, Diffuse Trial in Guangzhou (gemcitabine, vinorelbine and doxorubicin liposome, with or without
Recruiting
- Lymphoma, Large B-Cell, Diffuse
- gemcitabine, vinorelbine and doxorubicin liposome, with or without rituximab
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Aug 3, 2019
Systemic Microvascular Reactivity in Heart Transplant Patients
Recruiting
- Heart Transplantation
- skin microvascular reactivity
-
Rio de Janeiro, BrazilEduardo Tibiriçá
Feb 14, 2023
Pediatric Patients, Hematologic Malignancy, Other Hematologic Condition Trial in Aurora (CliniMACS Plus Instrument)
Not yet recruiting
- Pediatric Patients
- +2 more
- CliniMACS Plus Instrument
-
Aurora, ColoradoChildren's Hospital Colorado
Jun 29, 2022
Classical Hodgkin Lymphoma Trial in China (Tislelizumab, Salvage Chemotherapy)
Recruiting
- Classical Hodgkin Lymphoma
- Tislelizumab
- Salvage Chemotherapy
-
Beijing, Beijing, China
- +6 more
Jan 4, 2022
Hodgkin Disease Lymphoma Trial in China (Penpulimab, Investigator's choice of Chemotherapy)
Recruiting
- Hodgkin Disease Lymphoma
- Penpulimab
- Investigator's choice of Chemotherapy
-
Guangzhou, Guangdong, China
- +5 more
Feb 15, 2022
Primary Mediastinal Large B-cell Lymphoma Trial in Beijing (Decitabine, GVD chemo, SHR-1210)
Unknown status
- Primary Mediastinal Large B-cell Lymphoma
- Decitabine
- +2 more
-
Beijing, Beijing, China
- +1 more
Nov 29, 2018
Hypertension Trial in Florianopolis (Application Group (GA))
Not yet recruiting
- Hypertension
- Application Group (GA)
-
Florianopolis, Santa Catarina, BrazilUniversidade Federal de Santa Catarina
Oct 7, 2022
B-CD30 + Hodgkin Lymphoma International Multi-center
Completed
- Classical Hodgkin Lymphoma
- Relapsed or Refractory Classical Hodgkin Lymphoma
-
Busan, Korea, Republic ofPusan National University Hospital
Jun 3, 2021
Profiling Vulvodynia Based on Neurobiological and Behavioral
Completed
- Vulvodynia
-
Los Angeles, CaliforniaUniversity of California, Los Angeles (UCLA)
Oct 16, 2019
Peripheral T-Cell Lymphoma Trial in Saint Louis (Gemcitabine, Navelbine, Doxorubicin Hydrochloride Liposome Injection)
Terminated
- Peripheral T-Cell Lymphoma
- Gemcitabine
- +13 more
-
Saint Louis, MissouriWashington University
Apr 14, 2020
Lymphoma, Non-Hodgkin;Hodgkin Disease Trial in Jinan (R-CHOP/CHOPE or ABVD chemo regimen, R-CDOP/CDOPE or DBVD chemo regimen)
Unknown status
- Lymphoma, Non-Hodgkin;Hodgkin Disease
- R-CHOP/CHOPE or ABVD chemotherapy regimen
- R-CDOP/CDOPE or DBVD chemotherapy regimen
-
Jinan, Shandong, ChinaDepartment of Hematology, Provincial Hospital Affiliated to Shan
Apr 1, 2019
Pathophysiology of Gastrointestinal Graft-versus-Host Disease
Withdrawn
- Graft-Versus-Host-Disease
- (no location specified)
Oct 5, 2017
Rett Syndrome Trial in France (Blood sampling)
Completed
- Rett Syndrome
- Blood sampling
-
Besançon, France
- +8 more
Aug 26, 2016
Lymphoma Trial in Puerto Rico, United States (gemcitabine HCl, pegylated liposomal doxorubicin HCl, vinorelbine tartrate)
Completed
- Lymphoma
- gemcitabine hydrochloride
- +2 more
-
Anniston, Alabama
- +75 more
Jul 12, 2016
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin
Completed
- Adult Lymphocyte Depletion Hodgkin Lymphoma
- +4 more
- monoclonal antibody SGN-30
- +6 more
-
Chicago, IllinoisCancer and Leukemia Group B
Feb 10, 2015
AML, ALL, CLL Trial in Boston (Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF)
Completed
- AML
- +8 more
- Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jul 14, 2016
Multiple Myeloma, Leukemia, Lymphoma Trial in Houston (drug, procedure, other)
Completed
- Multiple Myeloma
- +2 more
- Fludarabine
- +4 more
-
Houston, TexasUT MD Anderson Cancer Center
May 23, 2012